High pressure liquid chromatography and electrospray ionization mass spectrometry are advantageously integrated into a two-levels approach to detection and identification of haemoglobin variants

Clinical and Laboratory Haematology

Volumn 27, Issue 2, 2005, Pages 111-119

  Caruso, D ^a   Crestani, M ^a   Mitro, N ^a   Da Riva, L ^a   Mozzi, R ^b   Sarpau, S ^b   Merlotti, C ^b   Franzini, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Haemoglobinopathies; High performance liquid chromatography; Mass spectrometry; Screening; Variant identification

Indexed keywords

DEOXYHEMOGLOBIN; HEMOGLOBIN BARI; HEMOGLOBIN C; HEMOGLOBIN D PUNJAB; HEMOGLOBIN E; HEMOGLOBIN LEPORE BOSTON; HEMOGLOBIN S; HEMOGLOBIN VARIANT; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; DIAGNOSTIC VALUE; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; HEMOGLOBIN CAMPERDOWN; HEMOGLOBIN HANDSWORTH; HEMOGLOBIN J OXFORD; HEMOGLOBIN K WOOLWICH; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCENEDESMUS; SCREENING TEST; SEQUENCE ANALYSIS; SOLUBILITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS; GENETIC SCREENING; HEMOGLOBINS; HEMOGLOBINS, ABNORMAL; HUMANS; METHODS; SOLUBILITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VARIATION (GENETICS);

EID: 17144419708     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00674.x     Document Type: Article

References (22)

1. Badens C., Lena-Russo D., Lacan P., Francina A., Promé D., Riou J., Geoffroy M., Ayavou T., Faster J., Galactéros F. & Wajcman H. (1999). Hb Toulon [α77(EF6)Pro → His]: a new variant due to a mutation in the α2 gene found during measurement of glycated haemoglobin. Haemoglobin 23, 367-371.
2. Balasubramaniam J., Phelan L. & Bain B.J. (2001) Evaluation of a new screening test for sickle cell haemoglobin. Clinical and Laboratory Haematology 23, 379-383.
3. 25(A2)Pro → Ala], an electrophoretically silent variant with impaired glycation. Clinical Chemistry 49, 137-143.
4. Bunn H.F., Forget B.C. & Ramney H.M. (1977) Human Haemoglobins. W.B. Saunders Company, Philadelphia. London, Toronto, pp. 220-222.
5. Caruso D., Da Riva L., Giavarini F., Galli G., Brambilla S., Luraschi P. & Franzini C. (2002) A haemoglobin variant found during glycohaemoglobin measurement, identified as Hb Toulon [α77(EF6)Pro → His] by tandem mass spectrometry. Haemoglobin 26, 197-199.
6. Caruso D., Crestani M., Da Riva L., Mitro N., Giavarini F., Mozzi R. & Franzini C. (2004) Mass spectrometry and DNA sequencing are complementary techniques for characterizing haemoglobin variants: the example of haemoglobin J Oxford. Haematologica 89, 608-609.
7. Dorn-Beineke A. & Frietsch T. (2002) Sickle cell disease - pathophysiology, clinical and diagnostic implications. Clinical Chemistry and Laboratory Medicine 40, 1075-1084.
8. Fucharoen S., Winichagoon P., Wisedpanichkij R., Sae-Ngow B., Sriphanich R., Oncoung W., Muangsapaya W., Chowthaworn J., Kanokpongsakdi S., Bunyaratvej A., Piankijagum A. & Dewaele C. (1998) Prenatal and postnatal diagnoses of thalassemias and haemoglobinopathies by HPLC. Clinical Chemistry 44, 740-748.
9. Harvey D. & Reynolds T. (1995) Serendipity and glycated haemoglobin assay: discovery of a new haemoglobin variant. Annals of Clinical Biochemistry 32, 325.
10. Itano H.A. & Pauling L. (1949) A rapid diagnostic test for sickle cell anemia. Blood 4, 66-68.
11. Lemée V., Hue G., Lahary A. & Lavoinne A. (1999) Détection fortuite d'anomalies de l'hémoglobine lors du dosage de l'hémoglobine glyquée par une technique de Chromatographie liquide haute pressione. Annales de Biologie Clinique 57, 713-716.
12. NCCLS (1986) Solubility Test for Confirming the Presence of Sicling Haemoglobins. Approved Standard. NCCLS Document H8-A2. NCCLS. Villanova. PA.
13. (NCCLS (1994) Detection of Abnormal Haemoglobin Using Cellulose Acetate Electrophoresis Second edition; Approved Standard. NCCLS Document H10-A. 2nd edn. National Committee for Clinical Laboratory Standards. Villanova, PA.
14. Rai D.K., Griffiths W.J., Alvelius G. & Landin B. (2001) Electrospray mass spectrometry: an efficient method to detect silent haemoglobin variants causing erythrocytosis. Clinical Chemistry 47, 1308-1311.
15. Rai D.K., Griffiths W.J., Landin B., Wild B.J., Alvelius G. & Green B.N. (2003) Accurate mass measurement by electrospray ionization quadrupole mass spectrometry: detection of variants differing by <6 Da from normal in human haemoglobin heterozygotes. Analytical Chemistry 75, 1978-1982.
16. Reynolds T.M., Harvey T.C., Green B.M., Smith A. & Hatland A.G. (2002) Hemoglobin Wayne in a British family: identification by electrospray ionization mass spectrometry. Clinical Chemistry 48, 2261-2263.
17. Riuo J., Godart C., Hurtrel D., Mathis M., Bimet C., Bardakdjian-Michau J., Préhu C., Wajcman H. & Galactéros F. (1997) Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clinical Chemistry 43, 34-39.
18. Sambrook J. & Russell D.W. (2001) Molecular Cloning: a Laboratory Manual Vol 2, 3th edn. Cold Spring Harbor Press, Cold Spring Harbor, NY.
19. Wada Y. (2002) Advanced analytical methods for haemoglobin variants. Journal of Chromatography B 781; 291-301.
20. Wajcman H., Préhu C., Bardakdjian-Michau J., Promé D., Riou J., Godart C., Mathis M., Hurtrel D. & Galactèros F. (2001) Abnormal haemoglobins: laboratory methods. Haemoglobin 25, 169-181.
21. Wave J.S., Eng B., Chut D.H.K., Powers P.J. & Lafferty J.D. (2000) Second report of Hb Toulon [α77(EF6)Pro → His] in a Canadian family of Italian descent. Haemoglobin 24, 359-360.
22. Wild B.J., Green B.N., Cooper E.K., Lalloz M.R.A., Erten S., Stephens A.D. & Layton D.M. (2001) Rapid identification of haemoglobin variants by electrospray ionization mass spectrometry. Blood Cells, Molecules, and Diseases 27, 691-704.